ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Minimal Residual Disease Negativity Is a New End Point of Myeloma Therapy.

Jean-Luc Harousseau et al.PubMed ↗Publisher ↗

No numbers read from the abstract.